ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Seven DNA Methylation Biomarker Prediction Models for Monitoring the Malignant Progression From Advanced Adenoma to Colorectal Cancer

Wang, Wei; Zhang, Xuecong; Zhu, Xiaohui; Cui, Wenzhi; Ye, Danli; Tong, Guihui; Huang, Dingpeng; Zhou, Juan; Lai, Xuwen; Yan, Guangning; Li, Xia; Fan, Jianbing*; Zhu, Hongwu*; Lei, Chengyong*南方医科大学
Frontiers in Oncology2022-5-12DOI: 10.3389/fonc.2022.827811
1被引11阅读
引用收藏
分享

摘要

Advanced adenoma (AA) holds a significantly increased risk for progression to colorectal cancer (CRC), and we developed a noninvasive DNA methylation prediction model to monitor the risk of AA progression to CRC. We analyzed the differential methylation markers between 53 normal mucosa and 138 CRC tissues, as well as those in cfDNA (cell-free DNA) between 59 AA and 68 early-stage CRC patients. We screened the overlapping markers between tissue DNA and cfDNA for model variables and optimized the selected variables. Then, we established a cfDNA methylation prediction model (SDMBP model) containing seven methylation markers that can effectively discriminate early-stage CRC and AA in the training and validation cohorts, and the AUC (area under the curve) reached 0.979 and 0.918, respectively. Our model also reached high precision (AUC=0.938) in detecting advanced CRC (stage III/IV) and presented better performance than serum CEA and CA199 in screening CRC. The cd-score of the SDMBP model could also robustly predict the TNM stage of CRC. Overall, our SDMBP model can monitor the malignant progression from AA to CRC, and may provide a noninvasive monitoring method for high-risk populations with AA.

学科与关键词

关键词
cell-free DNAadvanced adenomacolorectal cancermonitoringmethylation model
相关
加载中…
  • A novel cell-free DNA methylation-based model improves the early detection of colorectal cancer
    Wu, Xianrui; Zhang, Yunfeng; Hu, Tuo; He, Xiaowen; Zou, Yifeng; Deng, Qiling; Ke, Jia; Lian, Lei; He, Xiaosheng; Zhao, Dezhi; Cai, Xuyu; Chen, Zhiwei; Wu, Xiaojian; Fan, Jian-Bing*; Gao, Feng*; Lan, Ping*Molecular Oncology, 2021, 15(10): 2702-2714.被引 29
  • Genome-wide discovery of circulating cell-free DNA methylation biomarkers for colorectal cancer detection
    Fang, Qingxiao; Yuan, Ziming; Hu, Hanqing; Zhang, Weiyuan; Wang, Guiyu*; Wang, Xishan*Clinical Epigenetics, 2023, 15(1): 119.被引 4
  • Recurrence risk assessment for stage III colorectal cancer based on five methylation biomarkers in plasma cell-free DNA
    Wang, Wei; Zhu, Xiaohui; Zhang, Xuecong; Lei, Chengyong; Zeng, Zhicheng; Lan, Xiaoliang; Cui, Wenzhi; Wang, Feifei; Xu, Shaowan; Zhou, Juan; Wu, Xuehui; Deng, Haijun; Li, Xia; Fan, Jianbing*; Ding, Yanqing*; Huang, Zhongxi*; Liang, Li*Journal of Pathology, 2023, 259(4): 376-387.被引 1
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Oncology
发表日期
2022-05-12
卷期
第 12 卷
页码
827811
DOI
10.3389/fonc.2022.827811
期刊等级
3区
成果收录
SCIE
资助标注
Science and Technology Planning Project of Guangzhou [202102080525]; Science and Technology Planning Project of Guangdong Province, China [2017B020226005]; Scheme of Guangzhou for Leading Talents in Innovation and Entrepreneur ship [2016007]

作者

  • W

    Wang, Wei (第一作者)

  • Z

    Zhang, Xuecong

    southern med univ

查看全部 14 位作者收起作者
  • Z

    Zhu, Xiaohui

    southern med univ

  • C

    Cui, Wenzhi

  • Y

    Ye, Danli

  • T

    Tong, Guihui

  • H

    Huang, Dingpeng

  • Z

    Zhou, Juan

  • L

    Lai, Xuwen

  • Y

    Yan, Guangning

  • L

    Li, Xia

  • F

    Fan, Jianbing (通讯)

    southern med univ

  • Z

    Zhu, Hongwu (通讯)

  • L

    Lei, Chengyong (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417